Genomics and proteomics tools for compound mode-of-action studies in drug discovery

Author： Kley Nikolai   Ivanov Igor   Meier-Ewert Sebastian  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.4, 2004-06, pp. : 395-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genomics Strategies for Antifungal Drug Discovery - From Gene Discovery to Compound Screening

By  

Current Pharmaceutical Design, Vol. 8, Iss. 13, 2002-06 ,pp. : 1137-1154

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Encoding of Colloids for Combinatorial Libraries: Applications in Genomics, Proteomics and Drug Discovery

By  

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 6, 2003-12 ,pp. : 439-449

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

By  

Current Cancer Drug Targets, Vol. 4, Iss. 2, 2004-03 ,pp. : 111-124

Bentham Science Publishers

Access to resources Recommend Favorite

Investigating the Molecular Basis of Drug Action and Response: Chemocentric Genomics and Proteomics

By  

Current Drug Targets, Vol. 7, Iss. 4, 2006-04 ,pp. : 387-395

Bentham Science Publishers

Access to resources Recommend Favorite

Applying proteomics to drug discovery

By Stubberfield C.R.   Page M.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 1, 1999-01 ,pp. : 65-70

Informa Healthcare

Access to resources Recommend Favorite